The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Funny how CTEA and others still think they will win contract when they are behing the eight ball.
Lol that pool!! We talking Snooker now.
https://excaliburhealth.co.uk/news/excalibur-healthcare-services-using-new-testing-app-test-to-go-to-ensure-safety-of-snooker-world-seniors-players/
I hope you’re right TT, if we strike a testing contract I’m sure the sp will respond positively, perhaps surpassing the previous highs.
Generally when it drops on no news something happens the next day, there is definitely someone leaking info as it happens every time. Possibly shares allotted to another nhs trust tomorrow maybe?
Either way I’m holding tight if they can prove this works with several more tests and then after covid apply it to other diseases it’s going to be a brilliant money spinner and the opportunities are infinite
We need some news/update here to keep the sp buoyant..hopefully we’ll get something soon, otherwise the sp may continue to drift down.
Liberum have (perhaps) just now deliberately given the game away - according to their maths, given 100mn tests per week (a gross overstatement ), "Even at half the royalty it gets from its current testing partner, Excalibur, the maximum revenue potential" (given the aforesaid 100mn figure) "would be £4mln per week." Which works out at 8%.
Only slight gripe I have with this rns is the title ought to read something like.
‘Sensyne gains MHRA approval for magnifeye to be used in conjunction with DHSC covid testing’
I feel like the current title probably gets lost on people who aren’t already familiar with the share so we may be missing new investors...
Sorry missed off a key number...... 158,363,333
You can set your watch by sensyne I thought news would be coming after the sell off then the directors buying cheap shares had me thinking there must be news coming and here it is. A lot of money to be made on this share
Uplifted from the Gov. website: As of Thursday 6 May 2021 at 4:00pm 158,363,33 Virus tests include PCR tests conducted in laboratories and rapid lateral flow tests that give results in less than an hour, without needing to go to a laboratory. Would suggest the size of the prize is massive for MagnifEye & Excalibur Healthcare.
MagnifEye RNS, more info on this game changer approval
https://excaliburhealth.co.uk/news/excalibur-creates-complete-freedom-passport-solution-for-mass-population-use/